Cargando…
Curcumin enhances the lung cancer chemopreventive efficacy of phospho-sulindac by improving its pharmacokinetics
Phospho-sulindac (PS) is a safe sulindac derivative with promising anticancer efficacy in colon cancer. We evaluated whether its combination with curcumin could enhance the efficacy in the treatment of lung cancer. Curcumin, the principal bioactive component in turmeric, has demonstrated versatile c...
Autores principales: | CHENG, KA-WING, WONG, CHI C., MATTHEOLABAKIS, GEORGE, XIE, GANG, HUANG, LIQUN, RIGAS, BASIL |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787887/ https://www.ncbi.nlm.nih.gov/pubmed/23807084 http://dx.doi.org/10.3892/ijo.2013.1995 |
Ejemplares similares
-
Topical phospho-sulindac (OXT-328) is effective in the treatment of non-melanoma skin cancer
por: CHENG, KA WING, et al.
Publicado: (2012) -
Phospho-sulindac inhibits pancreatic cancer growth: NFATc1 as a drug resistance candidate
por: MURRAY, ONIKA T., et al.
Publicado: (2013) -
Phospho-valproic acid inhibits pancreatic cancer growth in mice: Enhanced efficacy by its formulation in poly-(L)-lactic acid-poly(ethylene glycol) nanoparticles
por: Mattheolabakis, George, et al.
Publicado: (2017) -
Targeting Mitochondrial STAT3 with the Novel Phospho-Valproic Acid (MDC-1112) Inhibits Pancreatic Cancer Growth in Mice
por: Mackenzie, Gerardo G., et al.
Publicado: (2013) -
Chemoprevention of Colon Cancer by DFMO, Sulindac, and NO-Sulindac Administered Individually or in Combinations in F344 Rats
por: Madka, Venkateshwar, et al.
Publicado: (2023)